Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T16:02:35.909Z.
Calculation as of: 2026-10-06T16:02:35.909Z.
Quote observation: 2026-10-06T16:00:23.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 1f516b86ce6f8a32b007838909cf85d374f635633f340bc308fa792387434ce1
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Fate Therapeutics, Inc.
Market Cap
$278.55M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$280.29M
Operating Cash Flow Yield
N/A
TTM Avg
2.67%
3Y Avg
2.67%
5Y Avg
2.67%
Market Cap
$274.62M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$283.83M
Operating Cash Flow Yield
N/A
TTM Avg
1.84%
3Y Avg
1.84%
5Y Avg
1.84%
Market Cap
$281.97M
Operating Cash Flow Yield
N/A
TTM Avg
41.23%
3Y Avg
41.23%
5Y Avg
41.23%
Market Cap
$268.71M
Operating Cash Flow Yield
N/A
TTM Avg
2.42%
3Y Avg
2.42%
5Y Avg
2.42%
Market Cap
$268.17M
Operating Cash Flow Yield
N/A
TTM Avg
17.72%
3Y Avg
21.01%
5Y Avg
14.11%
Market Cap
$267.91M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$288.40M
Operating Cash Flow Yield
N/A
TTM Avg
1.81%
3Y Avg
1.81%
5Y Avg
1.81%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fate Therapeutics, Inc. (FATE) | $278.55M | N/A | N/A | N/A | N/A |
| Aurora Cannabis Inc. (ACB)vs › | $280.29M | N/A | 2.67% | 2.67% | 2.67% |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $274.62M | N/A | N/A | N/A | N/A |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $283.83M | N/A | 1.84% | 1.84% | 1.84% |
| Indaptus Therapeutics, Inc. (INDP)vs › | $281.97M | N/A | 41.23% | 41.23% | 41.23% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $268.71M | N/A | 2.42% | 2.42% | 2.42% |
| OraSure Technologies, Inc. (OSUR)vs › | $268.17M | N/A | 17.72% | 21.01% | 14.11% |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $267.91M | N/A | N/A | N/A | N/A |
| Abeona Therapeutics Inc. (ABEO)vs › | $288.40M | N/A | 1.81% | 1.81% | 1.81% |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $289.63M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
